Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| Hs 578T | THZ1 | 0.0001 | 0.9718 | -0.02655 |
| T47D | Alvocidib | 0.0001 | 0.4725 | 0.01152 |
| CAL-120 | Alvocidib | 0.0001 | 0.9798 | -0.00283 |
| T47D | Alvocidib | 0.0001 | 0.9963 | -0.00690 |
| T47D | THZ531 | 0.0001 | 1.0923 | 0.00149 |
| T47D | THZ1 | 0.0001 | 0.9788 | -0.00709 |
| HCC1143 | THZ1 | 0.0001 | 0.9646 | -0.00625 |
| MCF7 | THZ1 | 0.0001 | 0.9954 | -0.00279 |
| HCC1395 | Alvocidib | 0.0001 | 1.4079 | -0.01132 |
| CAL-120 | THZ1 | 0.0001 | 1.0648 | -0.00175 |
| HCC1395 | Alvocidib | 0.0001 | 1.0356 | -0.02346 |
| HCC1395 | Alvocidib | 0.0001 | 0.9613 | -0.01557 |
| HCC1395 | THZ1 | 0.0001 | 0.9372 | -0.01925 |
| HCC1395 | THZ1 | 0.0001 | 1.0113 | -0.01997 |
| HCC1395 | THZ531 | 0.0001 | 1.1439 | -0.00141 |
| HCC1419 | Alvocidib | 0.0001 | 1.0656 | -0.00825 |
| HCC1395 | THZ531 | 0.0001 | 1.1608 | -0.01972 |
| HCC1395 | THZ531 | 0.0001 | 0.9765 | 0.02105 |
| HCC1419 | Alvocidib | 0.0001 | 1.1161 | -0.00419 |
| CAMA-1 | Alvocidib | 0.0001 | 0.9416 | 0.00887 |
| MCF7 | Alvocidib | 0.0001 | 1.1211 | -0.00267 |
| MCF7 | THZ1 | 0.0001 | 1.1397 | -0.00440 |
| MCF7 | Alvocidib | 0.0001 | 1.0415 | -0.00238 |
| MDA-MB-231 | THZ1 | 0.0001 | 0.9882 | -0.00418 |
| MDA-MB-231 | THZ1 | 0.0001 | 1.0329 | -0.00220 |